Pancreatic Cancer Research

ResearcherSalk Institute for Biological StudiesActive in the last 2 years

Geoffrey Myles Wahl

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3658-2279; OpenAlex author ID A5038885111; NIH RePORTER profile ID 1891534. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
2
Labs led
0
Collaborators
35
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 grant · 2025: none · 2026: 1 grant

Papers 4

  1. Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Co-author DOI 10.1038/s41586-021-04176-w↗
  2. Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Co-author DOI 10.1038/s41586-019-1130-6↗
  3. Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapy. Last author DOI 10.1371/journal.pone.0189051↗
  4. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. Co-author DOI 10.1016/j.cell.2014.08.007↗

Grants 2

  1. Core 3: Mouse Models Core (MM Core) P01CA265762↗
  2. Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity R01CA240909↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ronald M. Evans · 4 shared papers, 1 shared grant, 2014–2026 · strength 0.94
  2. Susan M Kaech · 1 shared grant, 2024 · strength 0.91
  3. Tony R. Hunter · 3 shared papers, 1 shared grant, 2014–2026 · strength 0.89
  4. Dannielle D. Engle · 1 shared paper, 1 shared grant, 2014–2026 · strength 0.74
  5. Herve Tiriac · 1 shared grant, 2026 · strength 0.71
  6. Reuben Shaw · 1 shared grant, 2026 · strength 0.71
  7. Kathleen E. DelGiorno · 3 shared papers, 2017–2021 · strength 0.20
  8. Maya Ridinger-Saison · 3 shared papers, 2017–2021 · strength 0.20
  9. Andrew M. Lowy · 3 shared papers, 2017–2021 · strength 0.20
  10. Timothy R. Donahue · 3 shared papers, 2014–2021 · strength 0.17
  11. Eric Andrew Collisson · 3 shared papers, 2014–2021 · strength 0.17
  12. Gaoyang Liang · 2 shared papers, 2019–2021 · strength 0.14
  13. Nikki K. Lytle · 2 shared papers, 2019–2021 · strength 0.14
  14. Yu Shi · 2 shared papers, 2019–2021 · strength 0.14
  15. Ruilian Xu · 2 shared papers, 2019–2021 · strength 0.14
  16. Peiwu Huang · 2 shared papers, 2019–2021 · strength 0.14
  17. Corina E. Antal · 2 shared papers, 2019–2021 · strength 0.14
  18. Carlos Roberto Becerra · 2 shared papers, 2019–2021 · strength 0.14
  19. Michael Anthony Hollingsworth · 2 shared papers, 2019–2021 · strength 0.14
  20. Paul M. Grandgenett · 2 shared papers, 2019–2021 · strength 0.14
  21. Erkut Hasan Borazanci · 2 shared papers, 2019–2021 · strength 0.14
  22. Tannishtha Reya · 2 shared papers, 2019–2021 · strength 0.14
  23. Ruijun Tian · 2 shared papers, 2019–2021 · strength 0.14
  24. Daniel D. Von Hoff · 2 shared papers, 2019–2021 · strength 0.14
  25. Dawn Jaquish · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.